Waltham, MA-based Synageva BioPharma announced the first closing of its $30 million round of venture financing. The financing was led by Baker Brothers Investments and included Tullis Dickerson and Four Partners. "This investment is a strong affirmation of the technological advances we have made with the Synageva Expression Platform," said CEO Sanj K. Patel, "the tremendous potential of our development programs, and the expertise of our science and management teams." Release